CTOs on the Move

Novasyte

www.novasyte.com

 
Novasyte partners with med-tech companies, offering outsourced commercial service teams for clinical, sales, field technical and recall support. Our flexible model enables us to build, deploy and manage teams that expand and contract to meet our clients` customer-facing needs. Program success is tracked and measured with our real-time business intelligence analytics that provide our clients with critical insights into their most important resources - their people and their customers.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.novasyte.com
  • 5999 Avenida Encinas Suite 100
    Carlsbad, CA USA 92008
  • Phone: 888.899.6682

Executives

Name Title Contact Details

Similar Companies

Oncologix

Oncologix is a diversified medical device and healthcare holding company. For its customers, Oncologix provides FDA approved medical devices and state licensed healthcare services. For its shareholders, Oncologix acquires profitable operations that build, maintain and nourish shareholder value. The Company`s corporate mission is to be the best small cap medical device and healthcare holding company in North America.

Omni Optical Products

Omni Optical Products is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lake Region Medical

Lake Region Medical collaborates with the world’s leading medical device companies to deliver life-changing innovations that enhance the lives of patients. Backed by decades of experience and clinical expertise, we help customers bring products from concept to point-of-care in the Cardio & Vascular and Advanced Surgical markets. Lake Region Medical offers fully-integrated outsourced manufacturing and engineering services, contract manufacturing, finished device assembly, original device development and supply chain management services.

CCS Medical Holdings

CCS Medical Holdings Inc. is a Clearwater, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EnteroMedics

EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals. vBloc Therapy is now approved by the Food and Drug Administration for weight loss in adults with a BMI of 40 to 45 kg/m2 or a BMI of 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels.* *Individuals should have first tried to lose weight by diet and exercise in a supervised program within the last 5 years before receiving the Maestro System.